AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy targets rare protein disease in major trial
Disease control CompletedThis study tested whether adding daratumumab to standard chemotherapy (CyBorD) helps people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 416 adults took part. The goal was to see if the combination leads to better blood res…
Matched conditions: AMYLOIDOSIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New PET/MR scan could spot nerve amyloid without a biopsy
Diagnosis CompletedThis study tested whether a special PET/MR scan using a radioactive tracer called F-18 florbetapir can detect amyloid protein buildup in the nerves of people with amyloidosis. Eight adults with confirmed nerve amyloidosis or other nerve diseases took part. The goal was to see if …
Matched conditions: AMYLOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New PET tracer could sharpen amyloidosis diagnosis
Diagnosis CompletedThis phase 2 trial tested a radioactive tracer called 124I-AT-01 to see how well it can measure amyloid buildup in organs like the heart, kidneys, liver, and spleen using PET/CT scans. 33 adults with systemic amyloidosis received the tracer twice, six weeks apart. The goal was to…
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Attralus, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 13:34 UTC
-
Hidden nerve disease found in carpal tunnel patients?
Knowledge-focused CompletedThis completed study in Russia checked how many people with carpal tunnel syndrome also have a rare inherited nerve condition called hereditary transthyretin amyloidosis. Researchers reviewed medical records of 721 patients and will test some for the genetic mutation. The goal is…
Matched conditions: AMYLOIDOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Protein clues could spot rare disease years early
Knowledge-focused CompletedThis study followed 37 people with a genetic risk for hereditary ATTR amyloidosis over five years. Researchers measured levels of misfolded proteins in the blood to see if they could detect the earliest signs of the disease. The goal is to develop a way to catch the condition bef…
Matched conditions: AMYLOIDOSIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Could your nose warn of a rare heart disease?
Knowledge-focused CompletedThis study checked how common smell and taste problems are in 51 people with cardiac amyloidosis, a rare disease where abnormal proteins build up in the heart. Researchers used a simple smell test called Sniffin' Sticks to measure these senses. The goal was to see if these issues…
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC